Quidel Corp (QDEL):企業の財務・戦略的SWOT分析

◆英語タイトル:Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1015FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Quidel Corp (QDEL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specimen collection devices, media and controls; and specialty products including metabolic bone markers and enzyme linked immunosorbent assays (ELISA) and reagents. The company offers its products to physician offices, hospitals, clinical and reference laboratories, universities, retail clinics, urgent care clinics, pharmacies and wellness screening centers. It distributes products through direct sales force and a network of national and regional distributors. It has presence in the US, Ireland and China, among others. Quidel is headquartered in San Diego, California, the US.

Quidel Corp Key Recent Developments

Feb 18,2021: Quidel Reports Fourth Quarter and Full Year 2020 Financial Results
Jan 07,2021: Quidel announces preliminary revenue for fourth quarter 2020; will present virtually at 39th Annual J.P. Morgan Healthcare Conference
Oct 29,2020: Quidel reports third quarter 2020 financial results
Oct 01,2020: Quidel announces preliminary revenue for third quarter 2020
Aug 24,2020: QUIDEL announces board change

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Quidel Corp – Key Facts
Quidel Corp – Key Employees
Quidel Corp – Key Employee Biographies
Quidel Corp – Major Products and Services
Quidel Corp – History
Quidel Corp – Company Statement
Quidel Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Quidel Corp – Business Description
Product Category: Cardiac Immunoassay
Overview
Performance
Product Category: Molecular Diagnostic Solutions
Overview
Performance
Product Category: Rapid Immunoassay
Overview
Performance
Product Category: Specialized Diagnostic Solutions
Overview
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Foreign
Performance
R&D Overview
Quidel Corp – Corporate Strategy
Quidel Corp – SWOT Analysis
SWOT Analysis – Overview
Quidel Corp – Strengths
Quidel Corp – Weaknesses
Quidel Corp – Opportunities
Quidel Corp – Threats
Quidel Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Quidel Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Quidel Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Quidel Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2021: Quidel Reports Fourth Quarter and Full Year 2020 Financial Results
Jan 07, 2021: Quidel announces preliminary revenue for fourth quarter 2020; will present virtually at 39th Annual J.P. Morgan Healthcare Conference
Oct 29, 2020: Quidel reports third quarter 2020 financial results
Oct 01, 2020: Quidel announces preliminary revenue for third quarter 2020
Aug 24, 2020: QUIDEL announces board change
Jul 30, 2020: Quidel reports second quarter 2020 financial results
Jul 30, 2020: Quidel to Hold Second Fiscal Quarter 2020 Financial Results Conference Call on July 30th, 2020
Jul 06, 2020: Quidel announces preliminary revenue for second quarter 2020
Jun 11, 2020: Quidel announces Jack Schuler will retire from Quidel’s Board of Directors
May 06, 2020: Quidel reports first quarter 2020 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Quidel Corp, Key Facts
Quidel Corp, Key Employees
Quidel Corp, Key Employee Biographies
Quidel Corp, Major Products and Services
Quidel Corp, History
Quidel Corp, Other Locations
Quidel Corp, Subsidiaries
Quidel Corp, Key Competitors
Quidel Corp, Ratios based on current share price
Quidel Corp, Annual Ratios
Quidel Corp, Annual Ratios (Cont...1)
Quidel Corp, Annual Ratios (Cont...2)
Quidel Corp, Interim Ratios
Quidel Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Quidel Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Quidel Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Quidel Corp (QDEL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Triphase Accelerator Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Triphase Accelerator Corp (Triphase Accelerator) is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company's pipeline products comprise marizomib, a brain-penetrant proteasome inhibitor, which is developed in both intravenou …
  • SAS Institute Inc.:企業の戦略・SWOT・財務分析
    SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report Summary SAS Institute Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vectren Corp (VVC):電力:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • Valener Inc (VNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investments in energy portfolio, the company offers storage, distribution, transportation and allied energy services. The company has interest in Gaz Metro and is its limited partner. Gaz Me …
  • Tapestry, Inc.:企業の戦略・SWOT・財務情報
    Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tapestry, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nasdaq, Inc. (NDAQ):企業の財務・戦略的SWOT分析
    Nasdaq, Inc. (NDAQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sandoz Inc:企業の戦略的SWOT分析
    Sandoz Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Bloomberg L.P.:企業の戦略・SWOT・財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Telenor ASA:企業の戦略・SWOT・財務情報
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • PMA Companies Inc:企業の戦略・SWOT・財務分析
    PMA Companies Inc - Strategy, SWOT and Corporate Finance Report Summary PMA Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hydra Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs. The company’s pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic areas including inflammation, pain, renal, anxiety and pulm …
  • Delta International Oil & Gas Inc (DLTZ):石油・ガス:M&Aディール及び事業提携情報
    Summary Delta International Oil & Gas Inc (Delta), formerly Delta Mutual Inc, is an oil and gas company. The company operates in the oil and gas acquisition and exploration activities. It also holds interests in oil and natural gas and development rights in Argentina. Delta’s oil and gas investments …
  • Cevec Pharmaceuticals GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Cevec Pharmaceuticals GmbH (Cevec) is a healthcare products company that offers production of biopharmaceuticals. The company produces recombinant glycoproteins and gene therapy vectors. It utilizes its CAP-Go technology developed expression system based on human cells, for the production of …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary HD Biosciences (China) Co Ltd (HDB), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a contract research organization that offers drug discovery research services. The organization develops and provides products such as mycoplasma detection kit and wash free calcium assay kit, among others …
  • SpineGuard SA (ALSGD):企業の財務・戦略的SWOT分析
    Summary SpineGuard SA (SpineGuard) is a medical device company that designs, develops and markets spine surgery products. The company offers PediGuard, a device that detects possible vertebral cortex perforation during pedicle preparation. It provides offers screw placement and alerts to surgeon pri …
  • Severn Trent Plc:企業の戦略・SWOT・財務分析
    Severn Trent Plc - Strategy, SWOT and Corporate Finance Report Summary Severn Trent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Dar Al Dawa Development & Investment Co Ltd (DADI):企業の財務・戦略的SWOT分析
    Dar Al Dawa Development & Investment Co Ltd (DADI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Deutsche Borse Ag
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆